A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)

Annals of Neurology

Volumn 47, Issue 4, 2000, Pages 422-429

  Yasuda, Minoru ^a,f   Takamatsu, Junichi ^b   D'Souza, Ian ^d   Crowther, R Anthony ^e   Kawamata, Toshio ^a   Hasegawa, Masato ^c   Hasegawa, Hiroshi ^a   Spillantini, Maria Grazia ^e   Tanimukai, Satoshi ^a   Poorkaj, Parvoneh ^d   Varani, Luca ^e   Varani, Gabriele ^e   Iwatsubo, Takeshi ^c   Goedert, Michel ^e   Schellenberg, Gerard D ^d   Tanaka, Chikako ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b Kikuchi National Hospital Division of Clinical Research   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TAU PROTEIN;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DNA SEQUENCE; FAMILIAL DISEASE; FEMALE; FRONTAL LOBE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL LOBE;

BRAIN; BRAIN CHEMISTRY; DEMENTIA; DETERGENTS; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; HEAT; HUMANS; INTRONS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PEDIGREE; POINT MUTATION; REGULATORY SEQUENCES, NUCLEIC ACID; RNA SPLICING; RNA, MESSENGER; SARCOSINE; SOLUBILITY; TAU PROTEINS;

EID: 0034074542     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200004)47:4<422::AID-ANA4>3.0.CO;2-G     Document Type: Article

References (46)

1. Spillantini MG, Goedert M. Tau protein pathology in neuro-degenerative diseases. Trends Neurosci 1998;21:428-433
2. Kertesz A, Munoz D. Pick's disease, frontotemporal dementia and Pick complex: emerging concepts. Arch Neurol 1998;55: 302-304
3. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825
4. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with inherited dementia FTDP-17. Nature 1998;393:702-705
5. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-7741
6. Dumanchin C, Camuzat A, Campion D, et al. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 1998;7:1825-1829
7. Clark LN, Poorkaj P, Wszolek Z, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 1998;95:13103-13107
8. Rizzu P, Van Swieten JC, Joosse M, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999;64:414-421
9. Iijima M, Tabira T, Poorkaj P, et al. A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 1999;10:497-501
10. Morris HR, Perez-Tur J, Janssen JC, et al. Mutation in the tau exon 10 splice site region in familial frontotemporal dementia. Ann Neurol 1999;45:270-271
11. Goedert M, Spillantini MG, Crowther RA, et al. Tau gene mutation in familial progressive subcortical gliosis. Nat Med 1999; 5:454-457
12. Mirra SS, Murrell JR, Gearing M, et al. Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 1999;58:335-345
13. Bird TD, Nochlin D, Poorkaj P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999;122: 741-756
14. D'Souza I, Poorkaj P, Hong M, et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 1999;96:5598-5603
15. Bugiani O, Murrell JR, Giaccone G, et al. Frontotemporal dementia and carticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999;58:667-677
16. Nasreddine ZS, Loginov M, Clark LN, et al. From genotype to phenotype: a clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 1999;45:704-715
17. Delisle MB, Murrell JR, Richardson R, et al. A mutation at codon 279 (N279K) in exon 10 of the tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol 1999;98:62-77
18. Houlden H, Baker M, Adamson J, et al. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999;46:243-248
19. Hulette CM, Pericak-Vance MA, Roses AD, et al. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke family 1684. J Neuropathol Exp Neurol 1999;58:859-866
20. Yasuda M, Kawamata T, Komure O, et al. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology 1999;53:864-868
21. Van Swieten JC, Stevens M, Rosso SM, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 1999;46:617-626
22. Goedert M, Spillantini MG, Jakes R, et al. Multiple isoforms of microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3:519-526
23. Goedert M, Spillantini MG, Potier MC, et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989;8:393-399
24. Goode BL, Feinstein SC. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J Cell Biol 1994;124:769-782
25. Gustke N, Trinczek B, Biernat J, et al. Domains of tau protein and interactions with microtubules. Biochemistry 1994;33: 9511-9522
26. Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 1990;9:4225-4230
27. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168
28. Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 1998;437:207-210
29. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998;282:1914-1917
30. Dayanandan R, Van Slegtenhorst M, Mack TG, et al. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett 1999;446:228-232
31. Hasegawa M, Smith MJ, Iijima M, et al. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett 1999;443:93-96
32. Nacharaju P, Lewis J, Easson C, et al. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett 1999;447:195-199
33. Goedert M, Jakes R, Crowther RA. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 1999;450:306-311
34. Spillantini MG, Crowther RA, Kamphorst W, et al. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 1998;153:1359-1363
35. Spillantini MG, Crowther RA, Goedert M. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 1996;92: 42-48
36. Grover A, Houlden H, Baker M, et al. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999;274:15134-15143
37. Varani L, Hasegawa M, Spillantini MG, et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 1999;96:8229-8234
38. Spillantini MG, Goedert M, Crowther RA, et al. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997;94:4113-4118
39. Takamatsu J, Kondo A, Ikegami K, et al. Selective expression of Ser199/202 phosphorylated tau in a case of frontotemporal dementia. Dement Geriatr Cogn Disord 1998;9:82-89
40. Kimura T, Ono T, Takamatsu J, et al. Sequential changes of tau site-specific phosphorylation during development of paired helical filaments. Dementia 1996;7:177-181
41. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418
42. Burn TC, Connors TD, Klinger KW, Landes GM. Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene 1995;161:183-187
43. Hasegawa M, Jakes R, Crowther RA, et al. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett 1996;384:25-30
44. Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci USA 1991;88:2288-2292
45. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-170
46. Goedert M, Crowther RA, Spillantini MG. Tau mutations cause frontotemporal dementias. Neuron 1998;21:955-958